Annual CAPEX
$362.00 M
+$77.40 M+27.20%
31 December 2023
Summary:
West Pharmaceutical Services annual capital expenditures is currently $362.00 million, with the most recent change of +$77.40 million (+27.20%) on 31 December 2023. During the last 3 years, it has risen by +$187.60 million (+107.57%). WST annual CAPEX is now at all-time high.WST CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$81.30 M
-$18.90 M-18.86%
30 September 2024
Summary:
West Pharmaceutical Services quarterly capital expenditures is currently $81.30 million, with the most recent change of -$18.90 million (-18.86%) on 30 September 2024. Over the past year, it has dropped by -$14.50 million (-15.14%). WST quarterly CAPEX is now -25.21% below its all-time high of $108.70 million, reached on 31 December 2023.WST Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$380.80 M
-$14.50 M-3.67%
30 September 2024
Summary:
West Pharmaceutical Services TTM capital expenditures is currently $380.80 million, with the most recent change of -$14.50 million (-3.67%) on 30 September 2024. Over the past year, it has increased by +$32.60 million (+9.36%). WST TTM CAPEX is now -3.67% below its all-time high of $395.30 million, reached on 30 June 2024.WST TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +27.2% | -15.1% | +9.4% |
3 y3 years | +107.6% | +24.5% | +65.0% |
5 y5 years | +245.8% | +156.5% | +220.5% |
WST CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +107.6% | -25.2% | +40.7% | -3.7% | +65.0% |
5 y | 5 years | at high | +245.8% | -25.2% | +156.5% | -3.7% | +220.5% |
alltime | all time | at high | +1516.1% | -25.2% | +2222.9% | -3.7% | +4178.6% |
West Pharmaceutical Services CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $81.30 M(-18.9%) | $380.80 M(-3.7%) |
June 2024 | - | $100.20 M(+10.6%) | $395.30 M(+6.7%) |
Mar 2024 | - | $90.60 M(-16.7%) | $370.50 M(+2.3%) |
Dec 2023 | $362.00 M(+27.2%) | $108.70 M(+13.5%) | $362.00 M(+4.0%) |
Sept 2023 | - | $95.80 M(+27.1%) | $348.20 M(+12.3%) |
June 2023 | - | $75.40 M(-8.2%) | $310.20 M(+3.1%) |
Mar 2023 | - | $82.10 M(-13.5%) | $300.90 M(+5.7%) |
Dec 2022 | $284.60 M(+12.3%) | $94.90 M(+64.2%) | $284.60 M(+6.9%) |
Sept 2022 | - | $57.80 M(-12.6%) | $266.20 M(-2.7%) |
June 2022 | - | $66.10 M(+0.5%) | $273.70 M(+3.5%) |
Mar 2022 | - | $65.80 M(-14.0%) | $264.50 M(+4.4%) |
Dec 2021 | $253.40 M(+45.3%) | $76.50 M(+17.2%) | $253.40 M(+9.8%) |
Sept 2021 | - | $65.30 M(+14.8%) | $230.80 M(+8.4%) |
June 2021 | - | $56.90 M(+4.0%) | $213.00 M(+8.1%) |
Mar 2021 | - | $54.70 M(+1.5%) | $197.00 M(+13.0%) |
Dec 2020 | $174.40 M(+38.0%) | $53.90 M(+13.5%) | $174.40 M(+10.3%) |
Sept 2020 | - | $47.50 M(+16.1%) | $158.10 M(+11.1%) |
June 2020 | - | $40.90 M(+27.4%) | $142.30 M(+9.7%) |
Mar 2020 | - | $32.10 M(-14.6%) | $129.70 M(+2.6%) |
Dec 2019 | $126.40 M(+20.7%) | $37.60 M(+18.6%) | $126.40 M(+6.4%) |
Sept 2019 | - | $31.70 M(+12.0%) | $118.80 M(+4.6%) |
June 2019 | - | $28.30 M(-1.7%) | $113.60 M(+7.7%) |
Mar 2019 | - | $28.80 M(-4.0%) | $105.50 M(+0.8%) |
Dec 2018 | $104.70 M(-20.0%) | $30.00 M(+13.2%) | $104.70 M(+0.5%) |
Sept 2018 | - | $26.50 M(+31.2%) | $104.20 M(-7.0%) |
June 2018 | - | $20.20 M(-27.9%) | $112.00 M(-7.7%) |
Mar 2018 | - | $28.00 M(-5.1%) | $121.30 M(-7.3%) |
Dec 2017 | $130.80 M(-23.1%) | $29.50 M(-14.0%) | $130.80 M(-12.1%) |
Sept 2017 | - | $34.30 M(+16.3%) | $148.80 M(-8.8%) |
June 2017 | - | $29.50 M(-21.3%) | $163.20 M(-3.3%) |
Mar 2017 | - | $37.50 M(-21.1%) | $168.70 M(-0.9%) |
Dec 2016 | $170.20 M(+29.3%) | $47.50 M(-2.5%) | $170.20 M(+1.6%) |
Sept 2016 | - | $48.70 M(+39.1%) | $167.50 M(+12.8%) |
June 2016 | - | $35.00 M(-10.3%) | $148.50 M(+5.9%) |
Mar 2016 | - | $39.00 M(-12.9%) | $140.20 M(+6.5%) |
Dec 2015 | $131.60 M(+17.4%) | $44.80 M(+50.8%) | $131.60 M(+15.3%) |
Sept 2015 | - | $29.70 M(+11.2%) | $114.10 M(+1.0%) |
June 2015 | - | $26.70 M(-12.2%) | $113.00 M(+2.0%) |
Mar 2015 | - | $30.40 M(+11.4%) | $110.80 M(-1.2%) |
Dec 2014 | $112.10 M(-28.0%) | $27.30 M(-4.5%) | $112.10 M(-12.1%) |
Sept 2014 | - | $28.60 M(+16.7%) | $127.50 M(-0.5%) |
June 2014 | - | $24.50 M(-22.7%) | $128.20 M(+1.9%) |
Mar 2014 | - | $31.70 M(-25.8%) | $125.80 M(-19.3%) |
Dec 2013 | $155.80 M(+18.0%) | $42.70 M(+45.7%) | $155.80 M(+6.2%) |
Sept 2013 | - | $29.30 M(+32.6%) | $146.70 M(+0.2%) |
June 2013 | - | $22.10 M(-64.2%) | $146.40 M(-9.2%) |
Mar 2013 | - | $61.70 M(+83.6%) | $161.30 M(+22.2%) |
Dec 2012 | $132.00 M(+36.4%) | $33.60 M(+15.9%) | $132.00 M(-0.9%) |
Sept 2012 | - | $29.00 M(-21.6%) | $133.20 M(+4.1%) |
June 2012 | - | $37.00 M(+14.2%) | $128.00 M(+17.0%) |
Mar 2012 | - | $32.40 M(-6.9%) | $109.40 M(+13.0%) |
Dec 2011 | $96.80 M(+31.2%) | $34.80 M(+46.2%) | $96.80 M(+12.6%) |
Sept 2011 | - | $23.80 M(+29.3%) | $86.00 M(+8.3%) |
June 2011 | - | $18.40 M(-7.1%) | $79.40 M(+4.6%) |
Mar 2011 | - | $19.80 M(-17.5%) | $75.90 M(+2.8%) |
Dec 2010 | $73.80 M(-31.5%) | $24.00 M(+39.5%) | $73.80 M(-5.9%) |
Sept 2010 | - | $17.20 M(+15.4%) | $78.40 M(-11.6%) |
June 2010 | - | $14.90 M(-15.8%) | $88.70 M(-10.2%) |
Mar 2010 | - | $17.70 M(-38.1%) | $98.80 M(-8.3%) |
Dec 2009 | $107.80 M(-22.5%) | $28.60 M(+4.0%) | $107.80 M(-16.9%) |
Sept 2009 | - | $27.50 M(+10.0%) | $129.70 M(-5.5%) |
June 2009 | - | $25.00 M(-6.4%) | $137.20 M(-4.1%) |
Mar 2009 | - | $26.70 M(-47.1%) | $143.00 M(+2.8%) |
Dec 2008 | $139.10 M(+3.7%) | $50.50 M(+44.3%) | $139.10 M(-9.5%) |
Sept 2008 | - | $35.00 M(+13.6%) | $153.70 M(+11.1%) |
June 2008 | - | $30.80 M(+35.1%) | $138.40 M(+5.0%) |
Mar 2008 | - | $22.80 M(-65.0%) | $131.80 M(-1.7%) |
Dec 2007 | $134.10 M | $65.10 M(+230.5%) | $134.10 M(+19.6%) |
Sept 2007 | - | $19.70 M(-18.6%) | $112.10 M(-0.6%) |
June 2007 | - | $24.20 M(-3.6%) | $112.80 M(+8.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $25.10 M(-41.8%) | $104.00 M(+15.2%) |
Dec 2006 | $90.30 M(+66.9%) | $43.10 M(+111.3%) | $90.30 M(+31.4%) |
Sept 2006 | - | $20.40 M(+32.5%) | $68.70 M(+10.3%) |
June 2006 | - | $15.40 M(+35.1%) | $62.30 M(+8.5%) |
Mar 2006 | - | $11.40 M(-47.0%) | $57.40 M(+6.1%) |
Dec 2005 | $54.10 M(-5.7%) | $21.50 M(+53.6%) | $54.10 M(+10.2%) |
Sept 2005 | - | $14.00 M(+33.3%) | $49.10 M(+3.8%) |
June 2005 | - | $10.50 M(+29.6%) | $47.30 M(-3.5%) |
Mar 2005 | - | $8.10 M(-50.9%) | $49.00 M(-14.6%) |
Dec 2004 | $57.40 M(-8.0%) | $16.50 M(+35.2%) | $57.40 M(-16.2%) |
Sept 2004 | - | $12.20 M(0.0%) | $68.50 M(-6.2%) |
June 2004 | - | $12.20 M(-26.1%) | $73.00 M(+2.0%) |
Mar 2004 | - | $16.50 M(-40.2%) | $71.60 M(+14.7%) |
Dec 2003 | $62.40 M(+73.3%) | $27.60 M(+65.3%) | $62.40 M(+53.7%) |
Sept 2003 | - | $16.70 M(+54.6%) | $40.60 M(+21.6%) |
June 2003 | - | $10.80 M(+47.9%) | $33.40 M(+2.1%) |
Mar 2003 | - | $7.30 M(+25.9%) | $32.70 M(-9.2%) |
Dec 2002 | $36.00 M(-20.4%) | $5.80 M(-38.9%) | $36.00 M(-11.1%) |
Sept 2002 | - | $9.50 M(-5.9%) | $40.50 M(-4.7%) |
June 2002 | - | $10.10 M(-4.7%) | $42.50 M(-3.4%) |
Mar 2002 | - | $10.60 M(+2.9%) | $44.00 M(-2.7%) |
Dec 2001 | $45.20 M(-5.2%) | $10.30 M(-10.4%) | $45.20 M(+12.2%) |
Sept 2001 | - | $11.50 M(-0.9%) | $40.30 M(-3.1%) |
June 2001 | - | $11.60 M(-1.7%) | $41.60 M(-8.2%) |
Mar 2001 | - | $11.80 M(+118.5%) | $45.30 M(-5.0%) |
Dec 2000 | $47.70 M(-24.8%) | $5.40 M(-57.8%) | $47.70 M(-14.7%) |
Sept 2000 | - | $12.80 M(-16.3%) | $55.90 M(-2.8%) |
June 2000 | - | $15.30 M(+7.7%) | $57.50 M(-17.7%) |
Mar 2000 | - | $14.20 M(+4.4%) | $69.90 M(+10.3%) |
Dec 1999 | $63.40 M(-17.3%) | $13.60 M(-5.6%) | $63.40 M(-19.8%) |
Sept 1999 | - | $14.40 M(-48.0%) | $79.10 M(-8.6%) |
June 1999 | - | $27.70 M(+259.7%) | $86.50 M(+23.7%) |
Mar 1999 | - | $7.70 M(-73.7%) | $69.90 M(-8.9%) |
Dec 1998 | $76.70 M(+123.0%) | $29.30 M(+34.4%) | $76.70 M(+31.6%) |
Sept 1998 | - | $21.80 M(+96.4%) | $58.30 M(+29.3%) |
June 1998 | - | $11.10 M(-23.4%) | $45.10 M(+5.9%) |
Mar 1998 | - | $14.50 M(+33.0%) | $42.60 M(+23.8%) |
Dec 1997 | $34.40 M(+8.5%) | $10.90 M(+26.7%) | $34.40 M(+12.4%) |
Sept 1997 | - | $8.60 M(0.0%) | $30.60 M(+4.1%) |
June 1997 | - | $8.60 M(+36.5%) | $29.40 M(0.0%) |
Mar 1997 | - | $6.30 M(-11.3%) | $29.40 M(-7.3%) |
Dec 1996 | $31.70 M(+1.3%) | $7.10 M(-4.1%) | $31.70 M(+2.3%) |
Sept 1996 | - | $7.40 M(-14.0%) | $31.00 M(-8.0%) |
June 1996 | - | $8.60 M(0.0%) | $33.70 M(+2.1%) |
Mar 1996 | - | $8.60 M(+34.4%) | $33.00 M(+5.4%) |
Dec 1995 | $31.30 M(+15.5%) | $6.40 M(-36.6%) | $31.30 M(-7.9%) |
Sept 1995 | - | $10.10 M(+27.8%) | $34.00 M(+10.0%) |
June 1995 | - | $7.90 M(+14.5%) | $30.90 M(+4.4%) |
Mar 1995 | - | $6.90 M(-24.2%) | $29.60 M(+9.2%) |
Dec 1994 | $27.10 M(-19.1%) | $9.10 M(+30.0%) | $27.10 M(+10.2%) |
Sept 1994 | - | $7.00 M(+6.1%) | $24.60 M(-3.5%) |
June 1994 | - | $6.60 M(+50.0%) | $25.50 M(-18.8%) |
Mar 1994 | - | $4.40 M(-33.3%) | $31.40 M(-6.3%) |
Dec 1993 | $33.50 M(+49.6%) | $6.60 M(-16.5%) | $33.50 M(-3.2%) |
Sept 1993 | - | $7.90 M(-36.8%) | $34.60 M(+6.5%) |
June 1993 | - | $12.50 M(+92.3%) | $32.50 M(+28.0%) |
Mar 1993 | - | $6.50 M(-15.6%) | $25.40 M(+13.4%) |
Dec 1992 | $22.40 M(-12.2%) | $7.70 M(+32.8%) | $22.40 M(+13.1%) |
Sept 1992 | - | $5.80 M(+7.4%) | $19.80 M(+3.7%) |
June 1992 | - | $5.40 M(+54.3%) | $19.10 M(-7.3%) |
Mar 1992 | - | $3.50 M(-31.4%) | $20.60 M(-19.2%) |
Dec 1991 | $25.50 M(-23.2%) | $5.10 M(0.0%) | $25.50 M(-10.8%) |
Sept 1991 | - | $5.10 M(-26.1%) | $28.60 M(-8.0%) |
June 1991 | - | $6.90 M(-17.9%) | $31.10 M(-4.9%) |
Mar 1991 | - | $8.40 M(+2.4%) | $32.70 M(-1.5%) |
Dec 1990 | $33.20 M(-3.2%) | $8.20 M(+7.9%) | $33.20 M(+32.8%) |
Sept 1990 | - | $7.60 M(-10.6%) | $25.00 M(+43.7%) |
June 1990 | - | $8.50 M(-4.5%) | $17.40 M(+95.5%) |
Mar 1990 | - | $8.90 M | $8.90 M |
Dec 1989 | $34.30 M | - | - |
FAQ
- What is West Pharmaceutical Services annual capital expenditures?
- What is the all time high annual CAPEX for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual CAPEX year-on-year change?
- What is West Pharmaceutical Services quarterly capital expenditures?
- What is the all time high quarterly CAPEX for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly CAPEX year-on-year change?
- What is West Pharmaceutical Services TTM capital expenditures?
- What is the all time high TTM CAPEX for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM CAPEX year-on-year change?
What is West Pharmaceutical Services annual capital expenditures?
The current annual CAPEX of WST is $362.00 M
What is the all time high annual CAPEX for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual capital expenditures is $362.00 M
What is West Pharmaceutical Services annual CAPEX year-on-year change?
Over the past year, WST annual capital expenditures has changed by +$77.40 M (+27.20%)
What is West Pharmaceutical Services quarterly capital expenditures?
The current quarterly CAPEX of WST is $81.30 M
What is the all time high quarterly CAPEX for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly capital expenditures is $108.70 M
What is West Pharmaceutical Services quarterly CAPEX year-on-year change?
Over the past year, WST quarterly capital expenditures has changed by -$14.50 M (-15.14%)
What is West Pharmaceutical Services TTM capital expenditures?
The current TTM CAPEX of WST is $380.80 M
What is the all time high TTM CAPEX for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM capital expenditures is $395.30 M
What is West Pharmaceutical Services TTM CAPEX year-on-year change?
Over the past year, WST TTM capital expenditures has changed by +$32.60 M (+9.36%)